[SCHEDULE 13G] Sotera Health Company SEC Filing
Sculptor Capital and affiliated entities report collective beneficial ownership of 14,750,000 common shares of Sotera Health Company, representing 5.19% of the outstanding class based on 284,046,606 shares. The stake is held across multiple related reporting persons (Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc. and Sculptor Master Fund, Ltd.), each reporting shared voting and dispositive power of 14,750,000 shares and no sole voting or dispositive power. The filing states these shares are held in accounts managed by Sculptor and Sculptor-II and calculates percentages using the issuer’s 424B7 disclosed share count. The filing includes certifications that the position was not acquired to change or influence control of the issuer.
Sculptor Capital e entità affiliate riportano una proprietà beneficiaria collettiva di 14.750.000 azioni ordinarie di Sotera Health Company, che rappresentano il 5,19% delle azioni in circolazione della classe basato su 284.046.606 azioni. La partecipazione è detenuta tra più soggetti rilevanti relati (Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc. e Sculptor Master Fund, Ltd.), ognuno riportando potere di voto e disposizioni condiviso su 14.750.000 azioni e nessun potere di voto o disposizione esclusivo. L'atto di deposito indica che queste azioni sono detenute in conti gestiti da Sculptor e Sculptor-II e calcola le percentuali utilizzando il numero di azioni divulgato dall’emittente nel 424B7. L’atto include certificazioni che la posizione non è stata acquisita per modificare o influire sul controllo dell’emittente.
Sculptor Capital y entidades afiliadas reportan una propiedad beneficiera colectiva de 14.750.000 acciones comunes de Sotera Health Company, que representan el 5,19% de las acciones en circulación de la clase según 284.046.606 acciones. La participación se mantiene entre múltiples personas reportantes relacionadas (Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc. y Sculptor Master Fund, Ltd.), cada una reportando poder de voto y disposición compartidos sobre 14.750.000 acciones y sin poder de voto o disposición exclusivo. La presentación indica que estas acciones se mantienen en cuentas gestionadas por Sculptor y Sculptor-II y calcula los porcentajes utilizando el recuento de acciones divulgado por el emisor en el 424B7. La presentación incluye certificaciones de que la posición no fue adquirida para cambiar o influir en el control del emisor.
Sculptor Capital 및 관련 계열사가 Sotera Health Company의 보통주 1,475만 주에 대한 집합적 수익 소유를 보고하며, 이는 발행 주식 284,046,606주를 기준으로 5.19%에 해당합니다. 지분은 여러 관련 보고 당사자(Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc. 및 Sculptor Master Fund, Ltd.)에 걸쳐 있으며 각 당사자는 14,750,000주에 대해 공동 의결 및 처분 권한을 보유하고 단독 의결권이나 처분권은 없습니다. 제출 문서는 이 주식이 Sculptor와 Sculptor-II가 관리하는 계정에 보유되어 있으며 공시된 주식 수를 바탕으로 발행인의 424B7에서 공개된 주식 수를 사용해 비율을 계산한다고 명시합니다. 제출 문서에는 이 포지션이 발행인의 지배권 변경이나 영향력을 행사하기 위해 취득된 것이 아님을 증명하는 인증이 포함되어 있습니다.
Sculptor Capital et les entités affiliées déclarent une détention bénéficiaire collective de 14 750 000 actions ordinaires de Sotera Health Company, représentant 5,19% des actions en circulation de la classe sur la base de 284 046 606 actions. La participation est détenue par plusieurs personnes ou entités liées (Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc. et Sculptor Master Fund, Ltd.), chacun déclarant un pouvoir de vote et de disposition partagé sur 14 750 000 actions et aucun pouvoir de vote ou de disposition seul. Le dépôt indique que ces actions sont détenues dans des comptes gérés par Sculptor et Sculptor-II et calcule les pourcentages en utilisant le nombre d’actions divulgué par l’émetteur dans le 424B7. Le dépôt comprend des certifications selon lesquelles la position n’a pas été acquise dans le but de modifier ou d’influer sur le contrôle de l’émetteur.
Sculptor Capital und verbundene Einheiten melden kollektiven wirtschaftlichen Eigentum an 14.750.000 Stammaktien der Sotera Health Company, die 5,19% der ausstehenden Stammaktien basierend auf 284.046.606 Aktien entsprechen. Die Beteiligung wird über mehrere verbundene meldende Personen gehalten (Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc. und Sculptor Master Fund, Ltd.), wobei jede/r geteilte Stimm- und Verfügungsgewalt über 14.750.000 Aktien besitzt und keine alleinige Stimm- oder Verfügungsgewalt. Die Einreichung gibt an, dass diese Aktien in von Sculptor und Sculptor-II verwalteten Konten gehalten werden und Prozentsätze unter Verwendung der vom Emittenten in 424B7 offen gelegten Aktienanzahl berechnet werden. Die Einreichung enthält Zertifizierungen, dass die Position nicht erworben wurde, um die Kontrolle des Emittenten zu verändern oder zu beeinflussen.
Sculptor Capital والشركات المرتبطة تقر بوجود ملكية مستفيدة جماعية لـ 14,750,000 سهمًا عاديًا في Sotera Health Company، تشكل 5.19% من الأسهم القائمة بناءً على 284,046,606 سهمًا. يتم الاحتفاظ بالحصة عبر عدة أشخاص مقدِّمين تقارير مرتبطين (Sculptor Capital LP، Sculptor Capital II LP، Sculptor Capital Holding Corp، Sculptor Capital Holding II LLC، Sculptor Capital Management, Inc. وSculptor Master Fund, Ltd.)، وكل واحد منهم يبلغ عن سلطة تصويت وتصرّف مشتركة على 14,750,000 سهم وليس لديه سلطة تصويت أو تصرّف منفردة. تنص العريضة على أن هذه الأسهم محفوظة في حسابات تديرها Sculptor وSculptor-II وتحسب النسب باستخدام عدد الأسهم الذي أعلنه المصدر في 424B7. وتتضمن العريضة شهادات بأن الوضع لم يُكتسب بهدف تعديل أو التأثير في سيطرة المصدر.
Sculptor Capital及其关联实体报告对Sotera Health Company的普通股共持有1,475万股,代表基于2.84046606亿股的在外流通股本的5.19%。此持股分布在多个相关报告人(Sculptor Capital LP、Sculptor Capital II LP、Sculptor Capital Holding Corp、Sculptor Capital Holding II LLC、Sculptor Capital Management, Inc.及Sculptor Master Fund, Ltd.)之下,每家公司对14,750,000股拥有共同投票和处置权,且没有单独的投票或处置权。备案称这些股票存于由Sculptor和Sculptor-II管理的账户中,并且以发行人披露的424B7中的股数来计算百分比。备案还包括声明,表明该头寸并非为改变或影响发行人控制权而取得。
- Clear disclosure of a >5% position (14,750,000 shares, 5.19%) by Sculptor and affiliates
- Consolidated reporting across related entities clarifies ownership and control relationships
- Filing classified as Schedule 13G, indicating the position is represented as passive rather than an attempt to influence control
- None.
Insights
TL;DR: A Delaware-based investment manager group reports a >5% passive stake in Sotera Health, disclosed under Schedule 13G.
The filing shows Sculptor and affiliated entities collectively hold 14.75 million shares, or 5.19% of Sotera Health, with shared voting and dispositive power across the reporting entities and no sole control. This is reported on a Schedule 13G, indicating the filer contends the position is passive and not intended to influence control. The ownership percentage is calculated using 284,046,606 outstanding shares per the issuer’s 424B7. For investors, a >5% passive stake signals a significant shareholder position that may be monitored for any future change in intent or transition to an active filing.
TL;DR: Multiple related entities disclosed coordinated beneficial ownership, consistent with common fund/advisory structures.
The schedule identifies a group of related Sculptor entities that may be deemed beneficial owners under SEC rules due to management and ownership relationships. All reporting persons declare shared voting and dispositive authority for the full stake, and the filing includes the required certification that the holdings are not for the purpose of changing control. The structure and cross-references to parent and general partner relationships are clearly disclosed, aiding transparency for governance and regulatory review.
Sculptor Capital e entità affiliate riportano una proprietà beneficiaria collettiva di 14.750.000 azioni ordinarie di Sotera Health Company, che rappresentano il 5,19% delle azioni in circolazione della classe basato su 284.046.606 azioni. La partecipazione è detenuta tra più soggetti rilevanti relati (Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc. e Sculptor Master Fund, Ltd.), ognuno riportando potere di voto e disposizioni condiviso su 14.750.000 azioni e nessun potere di voto o disposizione esclusivo. L'atto di deposito indica che queste azioni sono detenute in conti gestiti da Sculptor e Sculptor-II e calcola le percentuali utilizzando il numero di azioni divulgato dall’emittente nel 424B7. L’atto include certificazioni che la posizione non è stata acquisita per modificare o influire sul controllo dell’emittente.
Sculptor Capital y entidades afiliadas reportan una propiedad beneficiera colectiva de 14.750.000 acciones comunes de Sotera Health Company, que representan el 5,19% de las acciones en circulación de la clase según 284.046.606 acciones. La participación se mantiene entre múltiples personas reportantes relacionadas (Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc. y Sculptor Master Fund, Ltd.), cada una reportando poder de voto y disposición compartidos sobre 14.750.000 acciones y sin poder de voto o disposición exclusivo. La presentación indica que estas acciones se mantienen en cuentas gestionadas por Sculptor y Sculptor-II y calcula los porcentajes utilizando el recuento de acciones divulgado por el emisor en el 424B7. La presentación incluye certificaciones de que la posición no fue adquirida para cambiar o influir en el control del emisor.
Sculptor Capital 및 관련 계열사가 Sotera Health Company의 보통주 1,475만 주에 대한 집합적 수익 소유를 보고하며, 이는 발행 주식 284,046,606주를 기준으로 5.19%에 해당합니다. 지분은 여러 관련 보고 당사자(Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc. 및 Sculptor Master Fund, Ltd.)에 걸쳐 있으며 각 당사자는 14,750,000주에 대해 공동 의결 및 처분 권한을 보유하고 단독 의결권이나 처분권은 없습니다. 제출 문서는 이 주식이 Sculptor와 Sculptor-II가 관리하는 계정에 보유되어 있으며 공시된 주식 수를 바탕으로 발행인의 424B7에서 공개된 주식 수를 사용해 비율을 계산한다고 명시합니다. 제출 문서에는 이 포지션이 발행인의 지배권 변경이나 영향력을 행사하기 위해 취득된 것이 아님을 증명하는 인증이 포함되어 있습니다.
Sculptor Capital et les entités affiliées déclarent une détention bénéficiaire collective de 14 750 000 actions ordinaires de Sotera Health Company, représentant 5,19% des actions en circulation de la classe sur la base de 284 046 606 actions. La participation est détenue par plusieurs personnes ou entités liées (Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc. et Sculptor Master Fund, Ltd.), chacun déclarant un pouvoir de vote et de disposition partagé sur 14 750 000 actions et aucun pouvoir de vote ou de disposition seul. Le dépôt indique que ces actions sont détenues dans des comptes gérés par Sculptor et Sculptor-II et calcule les pourcentages en utilisant le nombre d’actions divulgué par l’émetteur dans le 424B7. Le dépôt comprend des certifications selon lesquelles la position n’a pas été acquise dans le but de modifier ou d’influer sur le contrôle de l’émetteur.
Sculptor Capital und verbundene Einheiten melden kollektiven wirtschaftlichen Eigentum an 14.750.000 Stammaktien der Sotera Health Company, die 5,19% der ausstehenden Stammaktien basierend auf 284.046.606 Aktien entsprechen. Die Beteiligung wird über mehrere verbundene meldende Personen gehalten (Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc. und Sculptor Master Fund, Ltd.), wobei jede/r geteilte Stimm- und Verfügungsgewalt über 14.750.000 Aktien besitzt und keine alleinige Stimm- oder Verfügungsgewalt. Die Einreichung gibt an, dass diese Aktien in von Sculptor und Sculptor-II verwalteten Konten gehalten werden und Prozentsätze unter Verwendung der vom Emittenten in 424B7 offen gelegten Aktienanzahl berechnet werden. Die Einreichung enthält Zertifizierungen, dass die Position nicht erworben wurde, um die Kontrolle des Emittenten zu verändern oder zu beeinflussen.